Immunogenicity and reactogenicity of heterologous ChAdOx1 nCoV-19/mRNA vaccination | Nature Medicine
Neutralization of SARS-CoV-2 spike 69/70 deletion, E484K and N501Y variants by BNT162b2 vaccine-elicited sera | Nature Medicine
Brief Communications in 2019 | Nature Medicine
Brief Communications | Nature Medicine
Resistance to autosomal dominant Alzheimer's disease in an APOE3 Christchurch homozygote: a case report | Nature Medicine
Brief Communications in 2019 | Nature Medicine
A serological assay to detect SARS-CoV-2 seroconversion in humans | Nature Medicine
Brief Communications in 2020 | Nature Medicine
p53 inhibits CRISPR–Cas9 engineering in human pluripotent stem cells | Nature Medicine
Development of a CRISPR/Cas9-based therapy for Hutchinson–Gilford progeria syndrome | Nature Medicine
Brief Communications | Nature Medicine
Brief Communications in 2020 | Nature Medicine
目次 | Nature Medicine | Nature Portfolio
Brief Communications in 2020 | Nature Medicine
SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes | Nature Medicine
Brief Communications in 2018 | Nature Medicine
Seasonal coronavirus protective immunity is short-lasting | Nature Medicine
Brief Communications in 2019 | Nature Medicine
Temporal dynamics in viral shedding and transmissibility of COVID-19 | Nature Medicine
Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19 | Nature Medicine
Brief Communications | Nature Medicine
Volume 27 Issue 5, May 2021
Brief Communications in 2017 | Nature Medicine
Brief Communications | Nature Medicine
目次 | Nature Medicine | Nature Portfolio
